Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
BMC Cancer|October 1, 2011
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markersEleonor Olsson, Gabriella Honeth, Pär-Ola Bendahl, et al.
Cancer Research|September 6, 2005
Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridizationGöran Jönsson, Tara L Naylor, Johan Vallon-Christersson, et al.
International Journal of Cancer|September 19, 2002
Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomyPål Møller, Ake Borg, D Gareth Evans, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 22, 2003
Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrierOskar T Johannsson, Synnöve Staff, Johan Vallon-Christersson, et al.
Genes, Chromosomes & Cancer|May 20, 2008
Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platformsRebeqa Gunnarsson, Johan Staaf, Mattias Jansson, et al.
Breast Cancer Research and Treatment|December 25, 2010
A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicingMads Thomassen, Inge Søkilde Pedersen, Ida Vogel, et al.
American Journal of Human Genetics|April 17, 2007
Recurrent 10q22-q23 deletions: a genomic disorder on 10q associated with cognitive and behavioral abnormalitiesJorune Balciuniene, Ningping Feng, Kelly Iyadurai, et al.
Blood|July 10, 2007
The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromesLars Nilsson, Patrik Edén, Eleonor Olsson, et al.
Cancer Medicine|October 25, 2013
High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancerInga Reynisdottir, Adalgeir Arason, Berglind O Einarsdottir, et al.
Breast Cancer Research and Treatment|July 15, 2009
Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE StudyJane C Figueiredo, Robert W Haile, Leslie Bernstein, et al.
Pageof 15